Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension
Circulation · 23.07.2024 · 150 (4) · 302-316
DOI: 10.1161/circulationaha.123.065304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 23.07.2024. Verfasst von Haiyang Tang und 36 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, De…. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Mice, Knockout, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, BLRD VA.
Abstract (Originalsprache)
BACKGROUND: The ubiquitin-proteasome system regulates protein degradation and the development of pulmonary arterial hypertension (PAH), but knowledge about the role of deubiquitinating enzymes in this process is limited. UCHL1 (ubiquitin carboxyl-terminal hydrolase 1), a deubiquitinase, has been shown to reduce AKT1 (AKT serine/threonine kinase 1) degradation, resulting in higher levels. Given that AKT1 is pathological in pulmonary hypertension, we hypothesized that UCHL1 deficiency attenuates PAH development by means of reductions in AKT1. METHODS: Tissues from animal pulmonary hypertension models as well as human pulmonary artery endothelial cells from patients with PAH exhibited increased vascular UCHL1 staining and protein expression. Exposure to LDN57444, a UCHL1-specific inhibitor, reduced human pulmonary artery endothelial cell and smooth muscle cell proliferation. Across 3 preclinical PAH models, LDN57444-exposed animals, Uchl1 knockout rats ( Uchl1 −/− ), and conditional Uchl1 knockout mice ( Tie2Cre-Uchl1 fl/fl ) demonstrated reduced right ventricular hypertrophy, right ventricular systolic pressures, and obliterative vascular remodeling. Lungs and pulmonary artery endothelial cells isolated from Uchl1 −/− animals exhibited reduced total and activated Akt with increased ubiquitinated Akt levels. UCHL1-silenced human pulmonary artery endothelial cells displayed reduced lysine(K)63-linked and increased K48-linked AKT1 levels. RESULTS: Supporting experimental data, we found that rs9321, a variant in a GC-enriched region of the UCHL1 gene, is associated with reduced methylation (n=5133), increased UCHL1 gene expression in lungs (n=815), and reduced cardiac index in patients (n=796). In addition, Gadd45α (an established demethylating gene) knockout mice ( Gadd45α −/− ) exhibited reduced lung vascular UCHL1 and AKT1 expression along with attenuated hypoxic pulmonary hypertension. CONCLUSIONS: Our findings suggest that UCHL1 deficiency results in PAH attenuation by means of reduced AKT1, highlighting a novel therapeutic pathway in PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Department of Clinical Laboratory, The First Affiliated Hospital of Guan…
- Department of Medicine and Arizona Health Sciences Center, Department of Cellular and Molecular Medicine, College of Medicine-Tucson, University of Arizona (A.G., G.G., N.A.W.).
- Krannert Cardiovascular Research Center (S.A.M., S.S., Y. Shi, S.R.N., S.C.-Y., R.D., A.A.D.), Indiana University, Indianapolis.
- College of Veterinary Medicine, Northwest A & F University, Yangling, China (C.B., Y. Sun, A.L., Y. Shi).
- Department of Medicine, and Departments of Medical & Molecular Genetics (T.-H.S.-A.), Indiana University, Indianapolis.
- Department of Echocardiography, Gansu Provincial Hospital, Lanzhou, China (A.C.).
ORCID-Profile: Haiyang Tang, Akash Gupta, Seth A Morrisroe, Changlei Bao, Tae-Hwi Schwantes-An, Geetanjali Gupta, Shuxin Liang, Ang Luo, Venkateswaran Ramamoorthi Elangovan, Shreya Sangam, Samisubbu R Naidu, Jia-Rong Jheng, Noel A Warfel, Katie A Lutz, Michael W Pauciulo, Yen-Chun Lai, Ali Javaheri, Daniel P Flaherty, Jason H Karnes, Olivier Boucherat, Sebastien Bonnet, Jason X-J Yuan, Jeffrey R Jacobson, Julio D Duarte, William C Nichols, Joe G N Garcia, Ankit A Desai
Förderung
- NHLBI NIH HHS
- BLRD VA
Zitieren
APA
Tang, H., Gupta, A., Morrisroe, S. A., Bao, C., Schwantes-An, T. H., Gupta, G., Liang, S., Sun, Y., Chu, A., Luo, A., Ramamoorthi Elangovan, V., Sangam, S., Shi, Y., Naidu, S. R., Jheng, J. R., Ciftci-Yilmaz, S., Warfel, N. A., Hecker, L., Mitra, S., …, & Desai, A. A. (2024). Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension. Circulation. https://doi.org/10.1161/circulationaha.123.065304
Vancouver
Tang H, Gupta A, Morrisroe SA, Bao C, Schwantes-An TH, Gupta G, et al. Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension. Circulation. 2024. doi:10.1161/circulationaha.123.065304
BibTeX
@article{Tang2024,
author = {Tang, Haiyang and Gupta, Akash and Morrisroe, Seth A and Bao, Changlei and Schwantes-An, Tae-Hwi and Gupta, Geetanjali and Liang, Shuxin and Sun, Yanan and Chu, Aiai and Luo, Ang and Ramamoorthi Elangovan, Venkateswaran and Sangam, Shreya and Shi, Yinan and Naidu, Samisubbu R and Jheng, Jia-Rong and Ciftci-Yilmaz, Sultan and Warfel, Noel A and Hecker, Louise and Mitra, Sumegha and Coleman, Anna W and Lutz, Katie A and Pauciulo, Michael W and Lai, Yen-Chun and Javaheri, Ali and Dharmakumar, Rohan and Wu, Wen-Hui and Flaherty, Daniel P and Karnes, Jason H and Breuils-Bonnet, Sandra and Boucherat, Olivier and Bonnet, Sebastien and Yuan, Jason X-J and Jacobson, Jeffrey R and Duarte, Julio D and Nichols, William C and Garcia, Joe G N and Desai, Ankit A},
title = {Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.123.065304}
}
EUVIMED